Online citations, reference lists, and bibliographies.

Total Abdominal Colectomy, Pelvic Peritonectomy, And End-ileostomy For The Surgical Palliation Of Mucinous Peritoneal Carcinomatosis From Non-gynecologic Cancer.

K. Stamou, S. Karakozis, P. Sugarbaker
Published 2003 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
BACKGROUND AND OBJECTIVES The optimal management of symptomatic advanced peritoneal carcinomatosis of non-gynecologic origin is not defined. Historic controls of surgical efforts report high postoperative mortality and morbidity rates with equivocal palliation. Novel surgical procedures need to be tested in terms of the impact on survival and quality of life. STUDY DESIGN We studied 46 consecutive patients who underwent total abdominal colectomy, pelvic peritonectomy with construction of an end-ileostomy for palliation of peritoneal carcinomatosis. RESULTS Total abdominal colectomy, pelvic peritonectomy, and end-ileostomy was successfully performed in 46 patients of median age of 54.4 years. Overall median survival was 10.7 months, with a mean follow-up period of 12 months. Patients with appendiceal malignancy had a median survival of 19.7 months. Prognosis was poorer for patients with colon cancer, who had a median survival of 7.0 months, while patients with primary peritoneal carcinomatosis had a median of 7.8 months. Postoperative morbidity and mortality rates were 19.5 and 8.6%, respectively. CONCLUSIONS Total abdominal colectomy, pelvic peritonectomy, and end-ileostomy is a technically feasible procedure and is advocated for the palliation of patients with peritoneal carcinomatosis of appendiceal origin. It is not clear if the procedure should be advocated for more invasive gastrointestinal malignancies.
This paper references
10.1200/JCO.2003.06.139
Surgery combined with peritonectomy procedures and intraperitoneal chemohyperthermia in abdominal cancers with peritoneal carcinomatosis: a phase II study.
O. Glehen (2003)
10.1002/(SICI)1096-9098(199606)62:2<93::AID-JSO4>3.0.CO;2-L
High mortality after abdominal operation in patients with large-volume malignant ascites.
G. P. Yazdi (1996)
Abdominal computed tomographic scan in the selection of patients with mucinous peritoneal carcinomatosis for cytoreductive surgery.
P. Jacquet (1995)
10.1002/1097-0142(19930401)71:7<2377::AID-CNCR2820710732>3.0.CO;2-H
Malignant ascites. A comparison of peritoneovenous shunting and nonoperative management
I. Gough (1993)
10.1007/s004230050246
Management of peritoneal-surface malignancy: the surgeon’s role
P. Sugarbaker (1999)
10.1053/EJSO.2000.1033
Quality of life after intraperitoneal hyperthermic chemotherapy (IPHC) for peritoneal carcinomatosis.
R. McQuellon (2001)
10.1002/(SICI)1097-0142(20000115)88:2<358::AID-CNCR16>3.0.CO;2-O
Peritoneal carcinomatosis from non‐gynecologic malignancies
B. Sadeghi (2000)
10.1007/978-1-4613-1247-5_23
Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis.
P. Jacquet (1996)
10.1007/978-1-4613-1247-5_17
Radiology of peritoneal carcinomatosis.
A. Archer (1996)
10.1016/0002-9610(91)90123-U
Small bowel obstruction in patients with a prior history of cancer.
J. Butler (1991)
10.1002/bjs.1800710311
Sites of recurrent tumour after ‘curative’ colorectal surgery: Implications for adjuvant therapy
J. Gilbert (1984)
10.1007/s002689900560
Second-look Surgery after Cytoreduction and Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis from Colorectal Cancer: Analysis of Prognostic Features
A. Portilla (1999)
Recurrent intraabdominal cancer with intestinal obstruction
Averbach Am (1995)
10.1016/S0002-9378(85)80045-4
Conservative management of small bowel obstruction.
B. Helmkamp (1985)
10.1002/1097-0142(19890115)63:2<364::AID-CNCR2820630228>3.0.CO;2-V
Peritioneal carcinomatosis in nongynecologic malignancy. A prospective study of prognostic factors
D. Chu (1989)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar